Dr. Cheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 S Grand Ave
Ste 800
Los Angeles, CA 90015Phone+1 213-748-1414
Education & Training
- University of California, San DiegoMPH, Epidemiology , 2022 - 2024
- University of California (San Diego) Medical CenterFellowship, Nephrology, 2020 - 2023
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2018 - 2020
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Internal Medicine, 2017 - 2018
- Keck School of Medicine of the University of Southern CaliforniaClass of 2017
Certifications & Licensure
- CA State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
- ABIMNephrology
Awards, Honors, & Recognition
- Gold Humanism Honor Society 2017
Publications & Presentations
PubMed
- The Vitamin D Metabolite Ratio Is Associated With Volumetric Bone Density in Older Men.Charles Ginsberg, Terri Blackwell, Jonathan H Cheng, O Alison Potok, Jane A Cauley
The Journal of Clinical Endocrinology and Metabolism. 2024-01-18 - 1 citationsDevelopment and Validation of Novel Free Vitamin D Equations: The Health Aging and Body Composition Study.Jonathan H Cheng, Andrew N Hoofnagle, Ronit Katz, Stephen B Kritchevsky, Michael G Shlipak
JBMR Plus. 2023-09-01 - 7 citationsThe Vitamin D Metabolite Ratio (VMR) is a Biomarker of Vitamin D Status That is Not Affected by Acute Changes in Vitamin D Binding Protein.Anushree Dugar, Andrew N Hoofnagle, Amber P Sanchez, David M Ward, Jody Corey-Bloom
Clinical Chemistry. 2023-07-05
Journal Articles
- Mandatory Research Biopsy Requirements Delay Initiation of Clinical TrialsJonathan Hin Cheng, Justin W Tiu-Lim, Anthony El-Khoueiry, Jorge J Nieva, Frontiers Oncology, 10/18/2019
- Tuberculosis following PD-1 blockade for cancer immunotherapyDaniel L. Barber, Shunsuke Sakai, Ragini R. Kudchadkar, Steven P. Fling, Tracey A. Day, Julie A. Vergara, David Ashkin, Jonathan H. Cheng, Lisa M. Lundgren, Vanessa N...., Science Translational Medicine, 1/16/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: